Interaction between interleukin 3 and dystrobrevin-binding protein 1 in schizophrenia

Schizophrenia Research

Volumn 106, Issue 2-3, 2008, Pages 208-217

  Edwards, Todd L ^b,e   Wang, Xu ^a   Chen, Qi ^a   Wormly, Brandon ^a   Riley, Brien ^a   O'Neill, F Anthony ^c   Walsh, Dermot ^d   Ritchie, Marylyn D ^b   Kendler, Kenneth S ^a   Chen, Xiangning ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d HEALTH RESEARCH BOARD   (Ireland)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Association; Epistasis; Multifactor Dimensionality Reduction algorithm; Pedigree Disequilibrium Test

Indexed keywords

DYSBINDIN; INTERLEUKIN 3;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EPISTASIS; FEMALE; GENE INTERACTION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC RISK; GENETIC TRAIT; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIFACTOR DIMENSIONALITY REDUCTION PEDIGREE DISEQUILIBRIUM TEST; NONPARAMETRIC TEST; PREDICTION; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

CARRIER PROTEINS; CHROMOSOMES, HUMAN, PAIR 5; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INTERLEUKIN-3; MALE; MODELS, GENETIC; PEDIGREE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SCHIZOPHRENIA;

EID: 56049084431     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2008.07.022     Document Type: Article

References (87)

1. Avgustin B., Wraber B., and Tavcar R. Increased Th1 and Th2 immune reactivity with relative Th2 dominance in patients with acute exacerbation of schizophrenia. Croat. Med. J. 46 (2005) 268-274
2. Bateson W. Mendel's Principles of Heredity (1909), Cambridge University Press, Cambridge
3. Bedell J.A., Korf I., and Gish W. MaskerAid: a performance enhancement to RepeatMasker. Bioinformatics 16 (2000) 1040-1041
4. Bessis A., Bechade C., Bernard D., and Roumier A. Microglial control of neuronal death and synaptic properties. Glia 55 (2007) 233-238
5. Brzustowicz L.M., Simone J., Mohseni P., Hayter J.E., Hodgkinson K.A., Chow E.W., and Bassett A.S. Linkage disequilibrium mapping of schizophrenia susceptibility to the CAPON region of chromosome 1q22. Am. J. Hum. Genet. 74 (2004) 1057-1063
6. Chavany C., Vicario-Abejon C., Miller G., and Jendoubi M. Transgenic mice for interleukin 3 develop motor neuron degeneration associated with autoimmune reaction against spinal cord motor neurons. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 11354-11359
7. Chen X., Dunham C., Kendler S., Wang X., Oneill F., Walsh D., and Kendler K.S. Regulator of G-protein signaling 4 (RGS4) gene is associated with schizophrenia in Irish high density families. Am. J. Med. Genet. 129B (2004) 23-26
8. Chen X., Levine L., and Kwok P.Y. Fluorescence polarization in homogeneous nucleic acid analysis. Genome. Res. 9 (1999) 492-498
9. Chen Q., Wang X., O'Neill F.A., Walsh D., Fanous A., Kendler K.S., and Chen X. Association study of CSF2RB with schizophrenia in Irish family and case-control samples. Mol. Psychiatry (2007) Advance online publication, 31 July 2007; doi:10.1038/sj.mp.4002051
10. Chen X., Wang X., Hossain S., O'Neill A.F., Walsh D., van den Oord E.J., Fanous A., and Kendler K.S. Interleukin 3 and schizophrenia: the impact of sex and family history. Mol. Psychiatry 12 (2007) 273-282
11. Chen X., Wang X., Hossain S., O'Neill F.A., Walsh D., Pless L., Chowdari K.V., Nimgaonkar V.L., Schwab S.G., Wildenauer D.B., Sullivan P.F., van den O.E., and Kendler K.S. Haplotypes spanning SPEC2, PDZ-G EF2 and ACSL6 genes are associated with schizophrenia. Hum. Mol. Genet. 15 (2006) 3329-3342
12. Chen X., Wang X., O'Neill A.F., Walsh D., and Kendler K.S. Variants in the catechol-o-methyltransferase (COMT) gene are associated with schizophrenia in Irish high-density families. Mol. Psychiatry 9 (2004) 962-967
13. Chiang C.S., Powell H.C., Gold L.H., Samimi A., and Campbell I.L. Macrophage/microglial-mediated primary demyelination and motor disease induced by the central nervous system production of interleukin-3 in transgenic mice. J. Clin. Invest. 97 (1996) 1512-1524
14. Chowdari K.V., Mirnics K., Semwal P., Wood J., Lawrence E., Bhatia T., Deshpande S.N., Thelma B.K., Ferrell R.E., Middleton F.A., Devlin B., Levitt P., Lewis D.A., and Nimgaonkar V.L. Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum. Mol. Genet. 11 (2002) 1373-1380
15. Chung R.H., Hauser E.R., and Martin E.R. The APL test: extension to general nuclear families and haplotypes and examination of its robustness. Hum. Hered. 61 (2006) 189-199
16. Cockayne D.A., Bodine D.M., Cline A., Nienhuis A.W., and Dunbar C.E. Transgenic mice expressing antisense interleukin-3 RNA develop a B-cell lymphoproliferative syndrome or neurologic dysfunction. Blood 84 (1994) 2699-2710
17. Corvin A., McGhee K.A., Murphy K., Donohoe G., Nangle J.M., Schwaiger S., Kenny N., Clarke S., Meagher D., Quinn J., Scully P., Baldwin P., Browne D., Walsh C., Waddington J.L., Morris D.W., and Gill M. Evidence for association and epistasis at the DAOA/G30 and d-amino acid oxidase loci in an Irish schizophrenia sample. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 144 (2007) 949-953
18. De L.V., Tharmalingam S., Muller D.J., Wong G., de Bartolomeis A., and Kennedy J.L. Gene-gene interaction between MAOA and COMT in suicidal behavior: analysis in schizophrenia. Brain Res. 1097 (2006) 26-30
19. Duan J., Martinez M., Sanders A.R., Hou C., Saitou N., Kitano T., Mowry B.J., Crowe R.R., Silverman J.M., Levinson D.F., and Gejman P.V. Polymorphisms in the trace amine receptor 4 (TRAR4) gene on chromosome 6q23.2 are associated with susceptibility to schizophrenia. Am. J. Hum. Genet. 75 (2004) 624-638
20. Fisher R. The correlation between relatives on the supposition of Mendelian inheritance. Trans. R. Soc. Edin. 52 (1918) 399-433
21. Fisher R.A. Statistical Methods for Research Workers vol. 11 (1950), Hafner, New York xv-354
22. Hahn L.W., and Moore J.H. Ideal discrimination of discrete clinical endpoints using multilocus genotypes. In. Silico. Biol. 4 (2004) 183-194
23. Hahn L.W., Ritchie M.D., and Moore J.H. Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 19 (2003) 376-382
24. Hodgkinson C.A., Goldman D., Jaeger J., Persaud S., Kane J.M., Lipsky R.H., and Malhotra A.K. Disrupted in schizophrenia 1 (DISC1): association with schizophrenia, schizoaffective disorder, and bipolar disorder. Am. J. Hum. Genet. 75 (2004) 862-872
25. Horvath S., Xu X., Lake S.L., Silverman E.K., Weiss S.T., and Laird N.M. Family-based tests for associating haplotypes with general phenotype data: application to asthma genetics. Genet. Epidemiol. 26 (2004) 61-69
26. Jarskog L.F., Glantz L.A., Gilmore J.H., and Lieberman J.A. Apoptotic mechanisms in the pathophysiology of schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry. 29 (2005) 846-858
27. Kendler K.S., Myers J.M., O'Neill F.A., Martin R., Murphy B., MacLean C.J., Walsh D., and Straub R.E. Clinical features of schizophrenia and linkage to chromosomes 5q, 6p, 8p, and 10p in the Irish Study of High-Density Schizophrenia Families. Am. J. Psychiatry. 157 (2000) 402-408
28. Konishi Y., Chui D.H., Kunishita T., Yamamura T., Higashi Y., and Tabira T. Demonstration of interleukin-3 receptor-associated antigen in the central nervous system. J. Neurosci. Res. 41 (1995) 572-582
29. Li J., and Ji L. Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity 95 (2005) 221-227
30. Liu K., and Muse S.V. PowerMarker: an integrated analysis environment for genetic marker analysis. Bioinformatics 21 (2005) 2128-2129
31. Livak K.J. Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet. Anal. 14 (1999) 143-149
32. Macgregor S., and Khan I.A. GAIA: an easy-to-use web-based application for interaction analysis of case-control data. BMC Med. Genet. 7 (2006) 34
33. Margolis R.L., Chuang D.M., and Post R.M. Programmed cell death: implications for neuropsychiatric disorders. Biol. Psychiatry 35 (1994) 946-956
34. Martin E.R., Bass M.P., Gilbert J.R., Pericak-Vance M.A., and Hauser E.R. Genotype-based association test for general pedigrees: the genotype-PDT. Genet. Epidemiol. 25 (2003) 203-213
35. Martin E.R., Bass M.P., Hauser E.R., and Kaplan N.L. Accounting for linkage in family-based tests of association with missing parental genotypes. Am. J. Hum. Genet. 73 (2003) 1016-1026
36. Martin E.R., Bass M.P., and Kaplan N.L. Correcting for a potential bias in the pedigree disequilibrium test. Am. J. Hum. Genet. 68 (2001) 1065-1067
37. Martin E.R., Monks S.A., Warren L.L., and Kaplan N.L. A test for linkage and association in general pedigrees: the pedigree disequilibrium test. Am. J. Hum. Genet. 67 (2000) 146-154
38. Martin E.R., Ritchie M.D., Hahn L., Kang S., and Moore J.H. A novel method to identify gene-gene effects in nuclear families: the MDR-PDT. Genet. Epidemiol. 30 (2006) 111-123
39. McClellan J.M., Susser E., and King M.C. Schizophrenia: a common disease caused by multiple rare alleles. Br. J. Psychiatry 190 (2007) 194-199
40. Mirnics K., Middleton F.A., Stanwood G.D., Lewis D.A., and Levitt P. Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Mol. Psychiatry 6 (2001) 293-301
41. Moore J.H. Computational analysis of gene-gene interactions using multifactor dimensionality reduction. Expert. Rev. Mol. Diagn. 4 (2004) 795-803
42. Moore J.H. Genome-wide analysis of epistasis using mutifactor dimensionality reduction: feature selection and construction in the domain of human genetics. In: Zu X., and Davidson I. (Eds). Knowledge Discovery and Data Mining: Challenges and Realities with Real World Data (2007), IGI Press, Hershey
43. Moore J.H., and Williams S.M. New strategies for identifying gene-gene interactions in hypertension. Ann. Med. 34 (2002) 88-95
44. Moore J.H., and Williams S.M. Traversing the conceptual divide between biological and statistical epistasis: systems biology and a more modern synthesis. Bioessays 27 (2005) 637-646
45. Natarajan C., Sriram S., Muthian G., and Bright J.J. Signaling through JAK2-STAT5 pathway is essential for IL-3-induced activation of microglia. Glia 45 (2004) 188-196
46. Neale B.M., and Sham P.C. The future of association studies: gene-based analysis and replication. Am. J. Hum. Genet. 75 (2004) 353-362
47. Nicodemus K.K., Kolachana B.S., Vakkalanka R., Straub R.E., Giegling I., Egan M.F., Rujescu D., and Weinberger D.R. Evidence for statistical epistasis between catechol-O-methyltransferase (COMT) and polymorphisms in RGS4, G72 (DAOA), GRM3, and DISC1: influence on risk of schizophrenia. Hum. Genet. 120 (2007) 889-906
48. Norton N., Kirov G., Zammit S., Jones G., Jones S., Owen R., Krawczak M., Williams N.M., O'Donovan M.C., and Owen M.J. Schizophrenia and functional polymorphisms in the MAOA and COMT genes: no evidence for association or epistasis. Am. J. Med. Genet. 114 (2002) 491-496
49. Norton N., Moskvina V., Morris D.W., Bray N.J., Zammit S., Williams N.M., Williams H.J., Preece A.C., Dwyer S., Wilkinson J.C., Spurlock G., Kirov G., Buckland P., Waddington J.L., Gill M., Corvin A.P., Owen M.J., and O'Donovan M.C. Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 141 (2006) 96-101
50. Nyholt D.R. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am. J. Hum. Genet. 74 (2004) 765-769
51. O'Donovan M.C., Williams N.M., and Owen M.J. Recent advances in the genetics of schizophrenia. Hum. Mol. Genet. 12 (2003) Spec No 2, R125-R133
52. Ott U., Reuter M., Hennig J., and Vaitl D. Evidence for a common biological basis of the Absorption trait, hallucinogen effects, and positive symptoms: epistasis between 5-HT2a and COMT polymorphisms. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 137 (2005) 29-32
53. Owen M.J., Williams N.M., and O'Donovan M.C. The molecular genetics of schizophrenia: new findings promise new insights. Mol. Psychiatry 9 (2004) 14-27
54. Pimm J., McQuillin A., Thirumalai S., Lawrence J., Quested D., Bass N., Lamb G., Moorey H., Datta S.R., Kalsi G., Badacsonyi A., Kelly K., Morgan J., Punukollu B., Curtis D., and Gurling H. The epsin 4 gene on chromosome 5q, which encodes the clathrin-associated protein enthoprotin, is involved in the genetic susceptibility to schizophrenia. Am. J. Hum. Genet. 76 (2005) 902-907
55. Powell H.C., Garrett R.S., Brett F.M., Chiang C.S., Chen E., Masliah E., and Campbell I.L. Response of glia, mast cells and the blood brain barrier, in transgenic mice expressing interleukin-3 in astrocytes, an experimental model for CNS demyelination. Brain. Pathol. 9 (1999) 219-235
56. Prasad K.M., Chowdari K.V., Nimgaonkar V.L., Talkowski M.E., Lewis D.A., and Keshavan M.S. Genetic polymorphisms of the RGS4 and dorsolateral prefrontal cortex morphometry among first episode schizophrenia patients. Mol. Psychiatry 10 (2005) 213-219
57. Qin S., Zhao X., Pan Y., Liu J., Feng G., Fu J., Bao J., Zhang Z., and He L. An association study of the N-methyl-d-aspartate receptor NR1 subunit gene (GRIN1) and NR2B subunit gene (GRIN2B) in schizophrenia with universal DNA microarray. Eur. J. Hum. Genet. 13 (2005) 807-814
58. Risch N., and Merikangas K. The future of genetic studies of complex human diseases. Science 273 (1996) 1516-1517
59. Ritchie M.D., Hahn L.W., and Moore J.H. Power of multifactor dimensionality reduction for detecting gene-gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity. Genet. Epidemiol. 24 (2003) 150-157
60. Ritchie M.D., Hahn L.W., Roodi N., Bailey L.R., Dupont W.D., Parl F.F., and Moore J.H. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am. J. Hum. Genet. 69 (2001) 138-147
61. Rozen S., and Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods. Mol. Biol. 132 (2000) 365-386
62. Schaid D.J. Evaluating associations of haplotypes with traits 2. Genet. Epidemiol. 27 (2004) 348-364
63. Schuldiner M., Collins S.R., Thompson N.J., Denic V., Bhamidipati A., Punna T., Ihmels J., Andrews B., Boone C., Greenblatt J.F., Weissman J.S., and Krogan N.J. Exploration of the function and organization of the yeast early secretory pathway through an epistatic miniarray profile. Cell 123 (2005) 507-519
64. Schulze T.G., Buervenich S., Badner J.A., Steele C.J., tera-Wadleigh S.D., Dick D., Foroud T., Cox N.J., MacKinnon D.F., Potash J.B., Berrettini W.H., Byerley W., Coryell W., DePaulo Jr. J.R., Gershon E.S., Kelsoe J.R., McInnis M.G., Murphy D.L., Reich T., Scheftner W., Nurnberger Jr. J.I., and McMahon F.J. Loci on chromosomes 6q and 6p interact to increase susceptibility to bipolar affective disorder in the national institute of mental health genetics initiative pedigrees. Biol. Psychiatry 56 (2004) 18-23
65. Schwab S.G., Knapp M., Mondabon S., Hallmayer J., Borrmann-Hassenbach M., Albus M., Lerer B., Rietschel M., Trixler M., Maier W., and Wildenauer D.B. Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. Am. J. Hum. Genet. 72 (2003) 185-190
66. Schwarz M.J., Kronig H., Riedel M., Dehning S., Douhet A., Spellmann I., Ackenheil M., Moller H.J., and Muller N. IL-2 and IL-4 polymorphisms as candidate genes in schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 256 (2006) 72-76
67. Segre D., Deluna A., Church G.M., and Kishony R. Modular epistasis in yeast metabolism. Nat. Genet. 37 (2005) 77-83
68. Sidak Z. Rectangular confidence regions for means of multivariate normal distributions. J. Am. Stat. Assoc. 62 (1967) 626 &
69. Stefansson H., Sigurdsson E., Steinthorsdottir V., Bjornsdottir S., Sigmundsson T., Ghosh S., Brynjolfsson J., Gunnarsdottir S., Ivarsson O., Chou T.T., Hjaltason O., Birgisdottir B., Jonsson H., Gudnadottir V.G., Gudmundsdottir E., Bjornsson A., Ingvarsson B., Ingason A., Sigfusson S., Hardardottir H., Harvey R.P., Lai D., Zhou M., Brunner D., Mutel V., Gonzalo A., Lemke G., Sainz J., Johannesson G., Andresson T., Gudbjartsson D., Manolescu A., Frigge M.L., Gurney M.E., Kong A., Gulcher J.R., Petursson H., and Stefansson K. Neuregulin 1 and susceptibility to schizophrenia. Am. J. Hum. Genet. 71 (2002) 877-892
70. Straub R.E., Jiang Y., MacLean C.J., Ma Y., Webb B.T., Myakishev M.V., Harris-Kerr C., Wormley B., Sadek H., Kadambi B., Cesare A.J., Gibberman A., Wang X., O'Neill F.A., Walsh D., and Kendler K.S. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am. J. Hum. Genet. 71 (2002) 337-348
71. Straub R.E., MacLean C.J., Ma Y., Webb B.T., Myakishev M.V., Harris-Kerr C., Wormley B., Sadek H., Kadambi B., O'Neill F.A., Walsh D., and Kendler K.S. Genome-wide scans of three independent sets of 90 Irish multiplex schizophrenia families and follow-up of selected regions in all families provides evidence for multiple susceptibility genes. Mol. Psychiatry 7 (2002) 542-559
72. Sullivan P.F. Spurious genetic associations. Biol. Psychiatry 61 (2007) 1121-1126
73. Sullivan P.F., Kendler K.S., and Neale M.C. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch. Gen. Psychiatry 60 (2003) 1187-1192
74. Sullivan P.F., O'Neill F.A., Walsh D., Ma Y., Kendler K.S., and Straub R.E. Analysis of epistasis in linked regions in the Irish Study of High-Density Schizophrenia Families. Am. J. Med. Genet. 105 (2001) 266-270
75. Talbot K., Cho D.S., Ong W.Y., Benson M.A., Han L.Y., Kazi H.A., Kamins J., Hahn C.G., Blake D.J., and Arnold S.E. Dysbindin-1 is a synaptic and microtubular protein that binds brain snapin. Hum. Mol. Genet. 15 (2006) 3041-3054
76. Talkowski M.E., Kirov G., Bamne M., Georgieva L., Torres G., Mansour H., Chowdari K.V., Milanova V., Wood J., McClain L., Prasad K., Shirts B., Zhang J., O'Donovan M.C., Owen M.J., Devlin B., and Nimgaonkar V.L. A network of dopaminergic gene variations implicated as risk factors for schizophrenia. Hum. Mol. Genet. 17 (2007) 747-758
77. Tong A.H., Evangelista M., Parsons A.B., Xu H., Bader G.D., Page N., Robinson M., Raghibizadeh S., Hogue C.W., Bussey H., Andrews B., Tyers M., and Boone C. Systematic genetic analysis with ordered arrays of yeast deletion mutants. Science 294 (2001) 2364-2368
78. Tong A.H., Lesage G., Bader G.D., Ding H., Xu H., Xin X., Young J., Berriz G.F., Brost R.L., Chang M., Chen Y., Cheng X., Chua G., Friesen H., Goldberg D.S., Haynes J., Humphries C., He G., Hussein S., Ke L., Krogan N., Li Z., Levinson J.N., Lu H., Menard P., Munyana C., Parsons A.B., Ryan O., Tonikian R., Roberts T., Sdicu A.M., Shapiro J., Sheikh B., Suter B., Wong S.L., Zhang L.V., Zhu H., Burd C.G., Munro S., Sander C., Rine J., Greenblatt J., Peter M., Bretscher A., Bell G., Roth F.P., Brown G.W., Andrews B., Bussey H., and Boone C. Global mapping of the yeast genetic interaction network. Science 303 (2004) 808-813
79. van den Oord E.J., Jiang Y., Riley B.P., Kendler K.S., and Chen X. FP-TDI SNP scoring by manual and statistical procedures: a study of error rates and types. Biotechniques 34 610-20 (2003) 622
80. van den Oord E.J., Sullivan P.F., Jiang Y., Walsh D., Neill F.A., Kendler K.S., and Riley B.P. Identification of a high-risk haplotype for the dystrobrevin binding protein 1 (DTNBP1) gene in the Irish Study of High-Density Schizophrenia Families. Mol. Psychiatry 8 (2003) 499-510
81. Vilella E., Costas J., Sanjuan J., Guitart M., De Diego Y., Carracedo A., Martorell L., Valero J., Labad A., De Frutos R., Najera C., Molto M.D., Toirac I., Guillamat R., Brunet A., Valles V., Perez L., Leon M., de Fonseca F.R., Phillips C., and Torres M. Association of schizophrenia with DTNBP1 but not with DAO, DAOA, NRG1 and RGS4 nor their genetic interaction. J. Psychiatr. Res. 42 (2007) 278-288
82. Weickert C.S., Straub R.E., McClintock B.W., Matsumoto M., Hashimoto R., Hyde T.M., Herman M.M., Weinberger D.R., and Kleinman J.E. Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain. Arch. Gen. Psychiatry 61 (2004) 544-555
83. Wigginton J.E., Cutler D.J., and Abecasis G.R. A note on exact tests of Hardy-Weinberg equilibrium. Am. J. Hum. Genet. 76 (2005) 887-893
84. Wittke-Thompson J.K., Pluzhnikov A., and Cox N.J. Rational inferences about departures from Hardy-Weinberg equilibrium. Am. J. Hum. Genet. 76 (2005) 967-986
85. Yasuno K., Ando S., Misumi S., Makino S., Kulski J.K., Muratake T., Kaneko N., Amagane H., Someya T., Inoko H., Suga H., Kanemoto K., and Tamiya G. Synergistic association of mitochondrial uncoupling protein (UCP) genes with schizophrenia. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 144 (2007) 250-253
86. Zammit S., Jones G., Jones S.J., Norton N., Sanders R.D., Milham C., McCarthy G.M., Jones L.A., Cardno A.G., Gray M., Murphy K.C., O'Donovan M.C., and Owen M.J. Polymorphisms in the MAOA, MAOB, and COMT genes and aggressive behavior in schizophrenia. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 128 (2004) 19-20
87. Zhao X., Qin S., Shi Y., Zhang A., Zhang J., Bian L., Wan C., Feng G., Gu N., Zhang G., He G., and He L. Systematic study of association of four GABAergic genes: glutamic acid decarboxylase 1 gene, glutamic acid decarboxylase 2 gene, GABA(B) receptor 1 gene and GABA(A) receptor subunit beta2 gene, with schizophrenia using a universal DNA microarray. Schizophr. Res. 93 (2007) 374-384